Omalizumab Superior to Oral Immunotherapy for Kids With Multi-Food Allergy

Watchdoq March 4, 2025
(MedPage Today) -- SAN DIEGO -- Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food allergy, largely because many patients couldn't tolerate OIT, findings from stage 2 of...

Read Full Article